Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mlnReuters • 04/25/24
Exploring Analyst Estimates for Labcorp (LH) Q1 Earnings, Beyond Revenue and EPSZacks Investment Research • 04/22/24
Labcorp (LH) Expected to Beat Earnings Estimates: Should You Buy? (Revised)Zacks Investment Research • 04/19/24
Labcorp (LH) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 04/18/24
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood DrawPRNewsWire • 04/15/24
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection KitPRNewsWire • 04/10/24
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development ProgramsPRNewsWire • 04/08/24
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical ResearchPRNewsWire • 04/05/24
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer ResearchPRNewsWire • 04/02/24
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With LabcorpBusiness Wire • 04/01/24
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessPRNewsWire • 03/28/24